Seeking Alpha

Dyne Therapeutics: Emergence As A Superior DM1/DMD Player Warrants Rating Upgrade

Upgrading Dyne Therapeutics to 'Buy' due to promising late-stage DM1 and DMD drug candidates and significant unmet need in both indications. Recent management changes and a more measured clinical ...
Business Wire

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dyne Therapeutics, Inc. (“Dyne” or “the Company”) ...
FOX8 Cleveland

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Possible Securities Law Violations And Impacted Investors Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dyne ...
KELOLAND News

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Securities Related Infractions And Investors Are Invited To Join The Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dyne ...
ksn.com

Ongoing Investigation Into Dyne Therapeutics, Inc. (DYN): Contact Levi & Korsinsky About Potential Fraud

NEW YORK, NY / ACCESS Newswire / June 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Dyne Therapeutics, Inc. ("Dyne Therapeutics, Inc.") (NASDAQ:DYN) ...
KRQE Blogs

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Possible Securities Law Violations And Impacted Investors Should Participate

LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dyne ...